Giant Cell Arteritis
RareAutoimmune
Giant Cell Arteritis is treated with 1 medication in our database, including AVTOZMA. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Celltrion. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Giant Cell Arteritis treatment below.
What help exists for Giant Cell Arteritis
5
drugs indexed
5
with copay cards
5
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Giant Cell Arteritis
5 totalAVTOZMA
tocilizumab · Celltrion
🎟💙Tocilizumab-anoh
tocilizumab · Sandoz
🎟💙TYENNE
Tocilizumab-aazg · Fresenius Kabi
🎟💙Rinvoq
Upadacitinib · AbbVie
🎟💙TOFIDENCE
Tocilizumab · Biogen
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Giant Cell Arteritis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Giant Cell Arteritis is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →